Oceania · Markets & Finance · Stockhead

Biocurious: Atomo is girding for the STD ‘comeback tour’ no-one wants to see

Published by Stockhead · Australia 2 h ago

Amid stubbornly high syphilis rates, pandemic-era Atomo is developing a point-of-care assay to detect active cases of the venereal disease. ... Read More The post Biocurious:…

Read the full article on Stockhead Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (stockhead.com.au)

Also worth reading

ABC Business

Biocurious: Atomo is girding for the STD ‘comeback tour’ no-one wants to see

Share

Also worth reading

Texan company plans to build new outback town for gas workers

Healius vs Australian Clinical Labs: Which ASX pathology share wins?

War has changed the economics of EV trucks in the Pilbara

Mine operator FQM Australia Nickel fined $810k over worker injury

ASX 200 Live Today - Tuesday, 6th October

Firmus IPO: Who’s the exit liquidity?